AstralBio, Inc.

Biotechnology company · Boston, Massachusetts, United States

AstralBio, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $957,408 sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

AstralBio at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2023

SEC CIK2048715

What does AstralBio do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $957,408 sold (2024).

Frequently asked questions about AstralBio

Where is AstralBio headquartered?

AstralBio, Inc. is headquartered in Boston, Massachusetts, United States.

What does AstralBio do?

AstralBio, Inc. is a biotechnology company.

When was AstralBio founded?

The earliest incorporation on record for AstralBio, Inc. is in 2023, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences